000047357 000__ 01043cam\a22003855i\4500
000047357 001__ 47357
000047357 003__ SzGeWIPO
000047357 005__ 20230503173132.0
000047357 006__ m\\\\eo\\d\\\\\\\\
000047357 007__ cr bn |||m|||a
000047357 008__ 230107s2022\\\\nyu\\\\\o\\\\\000\0\eng\d
000047357 035__ $$a(OCoLC)1369209305
000047357 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000047357 041__ $$aeng
000047357 24500 $$aBrazil: Penciclovir.
000047357 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2022
000047357 300__ $$a1 online resource
000047357 336__ $$atext$$2rdacontent
000047357 337__ $$acomputer$$2rdamedia
000047357 338__ $$aonline resource$$bcr$$2rdacarrier
000047357 4901_ $$aInternational Review of Intellectual Property Law & Competition Law ;$$vVolume 53, Issue 8
000047357 542__ $$fhttps://1.next.westlaw.com/Copyright
000047357 588__ $$aCrossref
000047357 590__ $$aPublished online: 2022
000047357 650_0 $$aIntellectual property.
000047357 650_0 $$aPatents$$zBrazil.
000047357 650_0 $$aPublic health.
000047357 650_0 $$aPharmaceuticals.
000047357 7731_ $$tInternational Review of Intellectual Property Law & Competition Law
000047357 7731_ $$wIIC
000047357 830_0 $$aInternational Review of Intellectual Property Law & Competition Law ;$$vVolume 53, Issue 8.
000047357 85641 $$uhttps://www.westlaw.com/Document/I8DBB2440437511EDAEEE91A21F90DAEC/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000047357 904__ $$aArticle
000047357 980__ $$aIIC